Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism.

MLA

Carnevale, Vincenzo, et al. “Potential Clinical Utility of a New IRMA for Parathyroid Hormone in Postmenopausal Patients with Primary Hyperparathyroidism.” Clinical Chemistry, vol. 50, no. 3, Mar. 2004, pp. 626–31. EBSCOhost, https://doi.org/10.1373/clinchem.2003.026328.

APA

Carnevale, V., Dionisi, S., Nofroni, I., Romagnoli, E., Paglia, F., De Geronimo, S., Pepe, J., Clemente, G., Tonnarini, G., & Minisola, S. (2004). Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clinical Chemistry, 50(3), 626–631. https://doi.org/10.1373/clinchem.2003.026328

Chicago

Carnevale, Vincenzo, Simona Dionisi, Italo Nofroni, Elisabetta Romagnoli, Federica Paglia, Simona De Geronimo, Jessica Pepe, Giovanni Clemente, Gianfranco Tonnarini, and Salvatore Minisola. 2004. “Potential Clinical Utility of a New IRMA for Parathyroid Hormone in Postmenopausal Patients with Primary Hyperparathyroidism.” Clinical Chemistry 50 (3): 626–31. doi:10.1373/clinchem.2003.026328.